Atrophic gastritis
Atrophic gastritis refers to a pathological state in which the gastric mucosa becomes thinner and the intrinsic glands decrease due to various causes. Its onset may be a long, multi-stage, multi-gene mutation accumulation process with the combined effects of multiple causes. Chronic gastritis recurrently causes atrophy and intestinal metaplasia of the gastric mucosal glands, and some glands may develop atypical hyperplasia or develop into cancer. This disease is more common in the elderly. Although atrophic gastritis is a precancerous lesion, cancer is closely related to dysplasia. Therefore, atrophy without obvious dysplasia has no obvious tendency to cancer.
-
Site of disease:
Stomach -
Infectious :
Not contagious -
Frequent population:
All groups -
Related symptoms:
Upper abdominal discomfort upper abdominal pain loss of appetite abdominal distension atrophic changes in gastric mucosa
Related Drugs
Vitazyme Capsules
Indication: At present, it is mainly used to treat atrophic gastritis, superficial gastritis, esophageal epithelial cell hyperplasia, and prevent cancer caused by cell hyperplasia. It can also be used as an auxiliary treatment for various types of hepatitis and riboflavin deficiency.
Manufacturer:
Sinopharm Group Tongjitang(Guizhou)Pharmaceutical Co., Ltd.
Sijunzi Granules
Manufacturer:
Jilin Jian Yisheng Pharmaceutical Co., Ltd.
Vitazyme Capsules
Indication: At present, it is mainly used to treat atrophic gastritis, superficial gastritis, esophageal epithelial cell hyperplasia, and prevent cancer caused by cell hyperplasia. It can also be used as an auxiliary treatment for various types of hepatitis and riboflavin deficiency.
Manufacturer:
China Resources Sanjiu (Tangshan) Pharmaceutical Co., Ltd.
Vitazyme Capsules
Indication: At present, it is mainly used to treat atrophic gastritis, superficial gastritis, esophageal epithelial cell hyperplasia, and prevent cancer caused by cell hyperplasia. It can also be used as an auxiliary treatment for various types of hepatitis and riboflavin deficiency.
Manufacturer:
Diaoyutai Pharmaceutical Group Jilin Changqing Pharmaceutical Co., Ltd.
Vitazyme Capsules
Indication: At present, it is mainly used to treat atrophic gastritis, superficial gastritis, esophageal epithelial cell hyperplasia, and prevent cancer caused by cell hyperplasia. It can also be used as an auxiliary treatment for various types of hepatitis and riboflavin deficiency.
Manufacturer:
Dalian Zhenao Pharmaceutical Co., Ltd.
Vitazyme Capsules
Indication: At present, it is mainly used to treat atrophic gastritis, superficial gastritis, esophageal epithelial cell hyperplasia, and prevent cancer caused by cell hyperplasia. It can also be used as an auxiliary treatment for various types of hepatitis and riboflavin deficiency.
Manufacturer:
Liaoning Haiyi Pharmaceutical Co., Ltd.
Vitazyme Capsules
Indication: At present, it is mainly used to treat atrophic gastritis, superficial gastritis, esophageal epithelial cell hyperplasia, and prevent cancer caused by cell hyperplasia. It can also be used as an auxiliary treatment for various types of hepatitis and riboflavin deficiency.
Manufacturer:
Mudanjiang Lingtai Medicdment Co., Ltd.
Vitazyme Capsules
Indication: At present, it is mainly used to treat atrophic gastritis, superficial gastritis, esophageal epithelial cell hyperplasia, and prevent cancer caused by cell hyperplasia. It can also be used as an auxiliary treatment for various types of hepatitis and riboflavin deficiency.
Vitazyme Capsules
Indication: At present, it is mainly used to treat atrophic gastritis, superficial gastritis, esophageal epithelial cell hyperplasia, and prevent cancer caused by cell hyperplasia. It can also be used as an auxiliary treatment for various types of hepatitis and riboflavin deficiency.
Xiangsha Yangwei Granules
Manufacturer:
Beijing Tongrentang Co., Ltd. Tongrentang Pharmaceutical Factory
Related Ingredients
-
Riboflavin list
83-88-5 -
Vitamin E list
2074-53-5 -
L-tert-Leucine list
20859-02-3